Wegovy Before and After (With Photos)

Starting Wegovy treatment (active ingredient: semaglutide) often raises questions about how quickly the medication works, how much weight patients can expect to lose, and when results become noticeable. While clinical studies have demonstrated significant weight loss with semaglutide, progress varies depending on individual health factors, dosage, and lifestyle habits.

Understanding the Wegovy weight loss timeline can help patients establish realistic expectations throughout treatment. This article explores what to expect during treatment, how dose escalation affects results, and demonstrate visible results from patients themselves.

How Much Weight Do People Usually Lose on Wegovy?

Wegovy is a prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate appetite and reduce food intake. It slows gastric emptying to help individuals feel full longer. Patients also can experience improvements in blood pressure and blood sugar control. Clinical evidence suggests that combining Wegovy with dietary modifications and regular physical activity can produce substantially greater weight loss than lifestyle interventions alone. In addition, patients with higher starting weights often lose greater absolute amounts.

A 2021 clinical trial (STEP 3) evaluated the effectiveness of once-weekly 2.4 mg semaglutide injections over 68 weeks. The study included adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) accompanied by at least one weight-related health condition. Participants were assigned to receive either semaglutide or a placebo. Both groups received intensive behavioral therapy, starting with an 8-week low-calorie meal-replacement diet, plus physical activity targets, allowing researchers to assess the additional benefits of medication. Because the lifestyle support was more intensive than in routine care, these figures are at the upper end of what patients usually see.

The reported outcomes demonstrated meaningful differences in weight reduction and waist circumference between the two groups.

The trial investigators concluded that “once-weekly subcutaneous semaglutide compared with placebo, used as an adjunct to intensive behavioral therapy and initial low-calorie diet, resulted in significantly greater weight loss during 68 weeks” (Wadden et al., JAMA, 2021).

These findings highlight Wegovy’s potential as an effective component of comprehensive obesity management. However, individual outcomes vary, and sustained weight management requires ongoing attention to nutrition, physical activity, treatment adherence, and medical follow-up.

Wegovy Weight Loss Results within the First Few Weeks

When starting body weight journey with Wegovy weight loss medication, you should understand its working principle and set realistic expectations for the whole treatment course, as well as for the first few weeks. Below, we’ll point out the main aspects you should pay attention to.

Week 1: Beginning Treatment

During the first week, patients start Wegovy at 0.25 mg once weekly, using a self-injection pen. Injections are administered into the abdomen, thigh, or upper arm, rotating the exact injection site each time.

Some individuals may notice significant appetite suppression or minor weight changes. Nausea, vomiting, constipation, and diarrhea are common early side effects as the body adjusts to semaglutide.

Week 2: Changes in Appetite

By the second week, Wegovy’s appetite-suppressing effects may become more noticeable. Patients might experience reduced hunger and increased fullness, helping them manage portion sizes.

Weight loss is typically modest at this stage, and visible physical changes are unlikely.

Week 3: Adjusting to Wegovy

During the third week, some patients experience improved appetite control and fewer gastrointestinal side effects as their bodies adapt to treatment.

However, individual responses vary, and persistent symptoms or limited appetite changes are not necessarily signs of treatment failure. Any concerning side effects should be discussed with a healthcare provider.

Week 4: Early Weight Loss Progress

By week four, weight reduction may become more apparent, particularly when Wegovy weight loss injection is combined with dietary changes and regular exercise. Some patients also notice improvements in medication tolerability.

After completing four weeks at 0.25 mg, the standard dosing schedule increases to 0.5 mg in week five. Healthcare providers may delay this adjustment if side effects remain troublesome.

Dose Escalation Schedule for the Medication

Wegovy treatment begins with a low dose that gradually increases to help the body adjust to semaglutide and minimize gastrointestinal side effects, including nausea, vomiting, and diarrhea.

The standard Wegovy dose escalation schedule follows a 16-week adjustment period:

Each dose is administered once weekly, with increases typically occurring every four weeks. Dose adjustments should always be supervised by a healthcare professional. If patients experience persistent gastrointestinal symptoms, their provider may recommend delaying escalation or temporarily returning to a lower dose.

The official labeling spells out how much flexibility there is: “If patients do not tolerate a dose during dosage escalation, consider delaying dosage escalation for 4 weeks” (Wegovy Prescribing Information, section 2.2). Slower escalation is a tolerability measure, not a way to increase weight loss.

The Optimal Wegovy Starting Dose

The recommended starting dose of Wegovy (semaglutide) is 0.25 mg once weekly for the first four weeks. This introductory dose allows the body to gradually adapt to the medication while reducing the risk of gastrointestinal side effects, such as nausea, vomiting, and diarrhea.

The initial dose is intended to improve tolerability rather than achieve maximum weight loss. Patients should not increase their dosage without guidance from their healthcare provider.

Patients Track Their Own Journey: Body Composition Changes

We’ve talked a lot about the average weight loss with the Wegovy injection, but let’s see the improvement ourselves! Below, we’re sharing examples of results that Wegovy users have shared publicly. Individual stories are not clinical evidence, and the average results from trials above are a more reliable guide to what to expect.

Patient 1

Improved their fitness routine and lost almost 90 pounds (40.8 kg).

Source: prescriptiondoctor.com

Patient 2

Another user dropped 100 pounds (45.4 kg) in one year.

Source: prescriptiondoctor.com

Patient 3

A participant lost 80 pounds (36.3 kg) after 10 months on Wegovy.

Source: prescriptiondoctor.com

Lifestyle Changes to Support the Results

Achieving optimal Wegovy weight loss results involves more than medication alone. Sustainable lifestyle adjustments, particularly improvements in nutrition and physical activity, play an essential role in supporting long-term weight management.

A balanced diet should prioritize lean protein, fiber-rich vegetables, whole grains, and other nutrient-dense foods to support satiety and overall health. Regular movement, including walking and resistance training, can further improve treatment outcomes. Individuals with limited mobility or low fitness levels can begin with manageable activities, such as taking short walks or reducing prolonged periods of sitting.

Physical activity is particularly important during weight loss, as it helps preserve lean muscle mass, supports metabolic health, and promotes a healthier body composition. Combining aerobic exercise with strength training may help minimize muscle loss as body weight decreases. Stress and sleep quality also affect weight loss on Wegovy.

Habits matter after treatment too. In the STEP 1 extension, “One year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss” (Wilding et al., Diabetes, Obesity and Metabolism, 2022). The authors concluded that ongoing treatment is needed to maintain the improvements.

For the best results, patients should follow a personalized weight management plan developed with a healthcare professional. This approach can help ensure that dietary changes, exercise routines, and Wegovy treatment align with individual health needs and long-term goals.

The Bottom Line: Lose Weight with Wegovy!

Wegovy can be an efficient option for long-term weight management, but achieving meaningful results requires time, consistency, and realistic expectations. While some patients notice reduced appetite and modest weight loss during the first few weeks, more significant changes typically develop over several months as the dosage gradually increases.

Following the recommended Wegovy dose escalation schedule, maintaining healthy eating habits, and staying physically active can help support sustainable results. Since individual responses vary, regular consultations with a healthcare professional are essential for monitoring progress, managing side effects, and adjusting treatment when necessary.

FAQs

How much weight can you lose on Wegovy?

In the STEP trials, adults on Wegovy 2.4 mg lost about 15% to 16% of their body weight on average over 68 weeks, compared with about 2% to 6% on placebo. In STEP 3, 86.6% lost at least 5% and 75.3% lost at least 10%. Results vary widely, and people with a higher starting weight often lose more in absolute pounds.

When will I see results on Wegovy?

Appetite changes often start in the first one or two weeks, but weight loss is usually modest during the first month because the dose is still low. Most people notice clearer changes after two to three months, as the dose approaches the 1.7 mg and 2.4 mg levels. Visible before-and-after differences typically take several months.

How long does it take to reach the full Wegovy dose?

The standard schedule takes 16 weeks: 0.25 mg for four weeks, then 0.5 mg, 1 mg and 1.7 mg for four weeks each, and 2.4 mg from week 17. If a dose is not tolerated, the label allows escalation to be delayed by four weeks, and the maintenance dose can be 1.7 mg if 2.4 mg is not tolerated.

Do you regain weight after stopping Wegovy?

Many people do. In the STEP 1 extension, participants who stopped semaglutide regained about two-thirds of the weight they had lost within a year, and improvements in blood pressure and blood sugar also faded. Keeping up diet and activity helps, but obesity is a chronic condition and long-term treatment is often needed to hold the result.

Are before and after photos a reliable guide to Wegovy results?

They show what is possible, not what is typical. Photos shared online usually come from people with the best outcomes and may reflect other changes such as intensive exercise. The average results from clinical trials, and a realistic plan agreed with a healthcare professional, are a better basis for expectations.

References

Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial. JAMA, 325(14), 1403-1413. https://doi.org/10.1001/jama.2021.1831

Novo Nordisk. (2024). WEGOVY (semaglutide) injection, for subcutaneous use: Prescribing information. U.S. National Library of Medicine, DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5e548d0-cc79-4c34-a3f5-e20a5b8b6564

Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725

Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183